Pennsylvania recalls
3,594 federal recalls affecting Pennsylvania in the last 12 months - 382 Pennsylvania-specific plus 3,212 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-07-29FDA-DeviceBoston ScientificClass IINationwideBoston Scientific FARASTAR PFA Generator recalled for incompatibility
Boston Scientific is replacing specific FARASTAR PFA generators which have a configuration that is not compatible for use with the FARAPOINT PFA catheter.
- 2026-07-29FDA-DeviceBoston ScientificClass IINationwideBoston Scientific FARASTAR PFA Generator recalled for incomplete labeling
Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
- 2026-07-29FDA-DeviceBoston ScientificClass IINationwideBoston Scientific FARASTAR ablation generator recalled for incomplete instructions
Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
- 2026-07-29FDA-DeviceBoston ScientificClass IINationwideBoston Scientific FARASTAR ablation generator recalled for incomplete instructions
Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
- 2026-07-29FDA-DeviceMedlineClass INationwideMedline surgical kits recalled for anesthetic quality issues
Medline Industries, LP is issuing a recall for specific Medline kits containing B. Braun convenience kits that include Bupivacaine Hydrochloride in Dextrose Injection, USP. B. Braun Medical Inc. was notified by their supplier, Spectra Medical Devices, LLC of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. Huons Co, Ltd. has issued a voluntary recall of this product due to quality issues.
- 2026-07-29FDA-DeviceWilcox IndustriesClass IINationwideWilcox BOSS Xe aiming devices need safety software update
Wilcox is notifying all customers who have purchased a product from the BOSS Xe family that a software enhancement to increase safety has been released and all units should be returned to implement this change.
- 2026-07-29FDA-FoodGellert GlobalClass IFusia Kimchi & Tofu Kimbap recalled for undeclared fish
Undeclared Allergen (Fish)
- 2026-07-29FDA-FoodTotal NutritionClass INationwideTNVitamins Moringa Capsules and Powder recalled for Salmonella
Contaminated with Salmonella
- 2026-07-29FDA-FoodGreen JeevaClass INationwideGreen Jeeva moringa powder recalled for Salmonella risk
Moringa Powder ingredient positive for salmonella
- 2026-07-29FDA-FoodModern Warrior LifeClass INationwideModern Warrior Ready supplement recalled for unapproved ingredients
FDA analysis revealed the presence of unapproved ingredients including tianeptine, 1,4 DMAA, and aniracetam.
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi Xylocaine recalled for particulate matter contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi Xylocaine injection recalled for particulate contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi Naropin recalled for particulate matter
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi lidocaine injection recalled for hair contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi glycopyrrolate injection recalled for particulate contamination
Presence of Particulate Matter: Hair was found in product
- 2026-07-29FDA-DrugRising PharmaClass IINationwideRising Cyproheptadine Hydrochloride Syrup recalled for precipitate
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility issue
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concern
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Digi Eye recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility risk
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugAscend LaboratoriesClass IINationwideAscend amlodipine-olmesartan tablets recalled for low drug content
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 125 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for low potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine recalled for reduced potency
Subpotent Drug
Get notified about new Pennsylvania recalls
Free weekly digest. Add Pennsylvania to your profile to filter alerts to your state.
Get the Sunday Brief